VR Resources Limited ("VR" or the "Company", TSXV: VRR) is pleased to announce that the 3D-array DCIP geophysical survey is now underway over the Copper Queen target on the Company's Bonita porphyry ...
AMD's Helios rack-scale solution based on the MI455X accelerators, the company's major hope for AI market, may slip to 2027, ...
Acer's 16-inch Predator Helios Neo 16S AI gaming laptop delivers a superb OLED display and a top-end processor in a sleek, ...
Helios Investment Partners has raised its takeover offer for London-listed payments firm CAB Payments. The consortium said it is offering $1.15 (84p) per share for CAB Payments, after its previous ...
Rejects $292 million takeover bid from Helios consortium Says bid undervalues company CAB Payments' shares jump 12.5% Feb 2 (Reuters) - CAB Payments Holdings (CABP.L), opens new tab rejected on Monday ...
CAB Payments chief Neeraj Kapur. London fintech CAB Payments has pushed back against another takeover proposal from African-focused private investment giant Helios. The firm – which was behind the ...
Other discounts worth checking out today include $28 off Sonic Racing: CrossWorlds Amazon Exclusive Edition for Nintendo ...
DeepMind, Google’s AI research lab, announced Genie 3 last August, showing off an AI system capable of generating interactive virtual environments in real-time. Now, Google has released an ...
This handout photo released by the US Defence Visual Information Distribution Service (DVIDS) shows the US Navy Arleigh Burke-class guided-missile destroyer USS Gravely (DDG 107) sailing in formation ...
This bulky, bizarre accessory for your Switch isn't exactly VR, but it is a lot more fun than I expected. I started with CNET reviewing laptops in 2009. Now I explore wearable tech, VR/AR, tablets, ...
This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. The Meta Quest 3S stands out as one of the easiest ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2025 and ...